6-Mercaptopurine, still valuable for the palliative treatment of acute myeloid leukaemia

Hematology

Volumn 6, Issue 4, 2001, Pages 231-240

  Daenen, Simon M G J ^a   de Wolf, Joost Th M ^a   Vellenga, Edo ^a   Van Imhoff, Gustaaf W ^a   Smit, Jan W ^a   van den Berg De Ruiter, Eva ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

6 Mercaptopurine; Acute myeloid leukaemia; Palliative treatment; Responders

Indexed keywords

ALLOPURINOL; AMSACRINE; ANTIBIOTIC AGENT; CYTARABINE; DAUNORUBICIN; MERCAPTOPURINE; PARACETAMOL;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; AGED; ANAMNESIS; ARTICLE; BLOOD CELL COUNT; BLOOD TRANSFUSION; CANCER CHEMOTHERAPY; CANCER PALLIATIVE THERAPY; CANCER SURVIVAL; CONTROLLED STUDY; DISEASE COURSE; DOSE RESPONSE; FEMALE; FEVER; FOLLOW UP; GASTROINTESTINAL SYMPTOM; HUMAN; INFECTION; KARYOTYPING; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MYELODYSPLASIA; PRIORITY JOURNAL; QUALITY OF LIFE; RETROSPECTIVE STUDY; SCORING SYSTEM; THROMBOCYTE COUNT;

EID: 0035721484     PISSN: 10245332     EISSN: None     Source Type: Journal    
DOI: 10.1080/10245332.2001.11746576     Document Type: Article

References (19)

1. "Survival in myeloblastic leukemia of adults"
2. "Behenoyl cytosine arabinoside, daunorubicin, 6-mercaptopurine, and prednisolone combination therapy for acute myelogenous leukemia in adults and prognostic factors related to remission duration and survival length"
3. "Nationwide randomized comparative study of daunorubicin and aclarubicin in combination with behenoyl cytosine arabinoside, 6-mercaptopurine, and prednisolone for previously untreated acute myeloid leukemia"
4. "A randomized comparison of maintenance treatment with androgens, immunotherapy, and chemotherapy in adult acute myelogenous leukemia. A Leukemia-Lymphoma Group Trial of the EORTC"
5. "Treatment of acute myeloid leukemia in elderly patients: The influence of maintenance therapy (BGM 84 protocol)"
6. "Late intensification with POMP chemotherapy prolongs survival in acute myelogenous leukemia-results of a Southwest Oncology Group study of rubidazone versus adriamycin for remission induction, prophylactic intensification, and levamisole maintenance"
7. "Definition of relapse and role of nonanthracycline drugs for consolidation in patients with acute promyelocytic leukemia: A joint study of the PETHEMA and GIMEMA Cooperative Groups"
8. "High-dose mercaptopurine followed by intermediate-dose cytarabine in relapsed acute leukemia"
9. "6-mercaptopurine for AML patients not eligible for aggressive remission induction"
10. "Clinical use of selective decontamination: The concept"
11. "Report of the National Cancer Institute-sponsored Workshop on Definitions of Diagnosis and Response in Acute Myeloid Leukemia"
12. "Low-dose cytarabine versus intensive chemotherapy in the treatment of acute non-lymphocytic leukemia in the elderly"
13. "On the value of intensive remission-induction chemotherapy in elderly patients of 65+ years with acute myeloid leukemia: A randomized phase III study of the European Organization for Research and Treatment of Cancer Leukemia Group"
14. "Treatment of acute myeloid leukemia in the elderly. A retrospective study"
15. "Acute myelogenous leukaemia in the elderly: Retrospective study of 235 consecutive patients"
16. "Pharmacokinetic case for giving 6-mercaptopurine maintenance doses at night"
17. "The effect of food on the oral administration of 6-mercaptopurine"
18. "Genetic polymorphism of thiopurine-S-methyltransferase: Molecular mechanisms and clinical implications"
19. "Report of an international working group to standardize response criteria for myelodysplastic syndromes"